% Expired Patents = 11.1

EPO Patents = 3

Forward Citations = 103

Loading Chart...

4 inventors (with patents filed for the assignee):

Roland Buelow (9 out of 34 patents)

Josef Platzer (7 out of 7 patents)

Wim Van Schooten (5 out of 19 patents)

4. Jens-Ulrich Buelow (1 out of 1 patent)

9 patents: Sort by Forward Citations

1. 11230697 - Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals (2022-01-25),

2. 10370641 - Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals (2019-08-06),

3. RE47131 - Humanized immunoglobulin loci (2018-11-19),

4. 8652842 - Humanized immunoglobulin loci (2014-02-18),

5. 8410333 - Humanized immunoglobulin loci (2013-04-02),

6. 8354568 - Suppression of B-cell apoptosis in transgenic animals expressing humanized immunoglobulin (2013-01-15),

7. 7919672 - Suppression of B-cell apoptosis in transgenic animals expressing humanized immunoglobulin (2011-04-05),

8. 7585668 - Humanized immunoglobulin loci (2009-09-08),

9. 7129084 - Production of humanized antibodies in transgenic animals (2006-10-31),

Company Overview

Therapeutic Human Polyclonals Inc. is a leading biotech company specializing in the development of human polyclonal antibodies for therapeutic use. With a focus on treating diseases such as cancer, autoimmune disorders, and infectious diseases, our innovative approach offers personalized treatments for patients. Our team of scientists and researchers work tirelessly to discover and develop novel therapies that have the potential to revolutionize the field of medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#269 in Mountain View, CA

#7,745 in California

#32,605 in US

Mountain View, CA, United States of America

Therapeutic Human Polyclonals Inc.

Forward Citations = 103

4 inventors:

Roland Buelow (9 out of 34 patents)

Josef Platzer (7 out of 7 patents)

Wim Van Schooten (5 out of 19 patents)

4. Jens-Ulrich Buelow (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Therapeutic Human Polyclonals Inc.. Retrieved from https://idiyas.com/company/therapeutic-human-polyclonals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]